Cargando…
Advances in the roles of glycyrrhizic acid in cancer therapy
Since the first 70 years of reporting cancer chemotherapy, malignant tumors have been the second most common cause of death in children and adults. Currently, the commonly used anti-cancer methods include surgery, chemotherapy, radiotherapy, and immunotherapy. Although these treatment methods could...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463042/ https://www.ncbi.nlm.nih.gov/pubmed/37649893 http://dx.doi.org/10.3389/fphar.2023.1265172 |
_version_ | 1785098166482239488 |
---|---|
author | Zhang, Yuqian Sheng, Zixuan Xiao, Jing Li, Yang Huang, Jie Jia, Jinjing Zeng, Xiansi Li, Li |
author_facet | Zhang, Yuqian Sheng, Zixuan Xiao, Jing Li, Yang Huang, Jie Jia, Jinjing Zeng, Xiansi Li, Li |
author_sort | Zhang, Yuqian |
collection | PubMed |
description | Since the first 70 years of reporting cancer chemotherapy, malignant tumors have been the second most common cause of death in children and adults. Currently, the commonly used anti-cancer methods include surgery, chemotherapy, radiotherapy, and immunotherapy. Although these treatment methods could alleviate cancer, they lead to different forms of side effects and have no particularly significant effect on prolonging the patients’ life span. Glycyrrhizic acid (GL), a native Chinese herbal extract, has a wide range of pharmacological effects, such as anti-cancer, anti-inflammatory, antioxidant, and immune regulation. In this review, the anti-cancer effects and mechanisms of GL are summarized in various cancers. The inhibition of GL on chemotherapy-induced side effects, including hepatotoxicity, nephrotoxicity, genotoxicity, neurotoxicity and pulmonary toxicity, is highlighted. Therefore, GL may be a promising and ideal drug for cancer therapy. |
format | Online Article Text |
id | pubmed-10463042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104630422023-08-30 Advances in the roles of glycyrrhizic acid in cancer therapy Zhang, Yuqian Sheng, Zixuan Xiao, Jing Li, Yang Huang, Jie Jia, Jinjing Zeng, Xiansi Li, Li Front Pharmacol Pharmacology Since the first 70 years of reporting cancer chemotherapy, malignant tumors have been the second most common cause of death in children and adults. Currently, the commonly used anti-cancer methods include surgery, chemotherapy, radiotherapy, and immunotherapy. Although these treatment methods could alleviate cancer, they lead to different forms of side effects and have no particularly significant effect on prolonging the patients’ life span. Glycyrrhizic acid (GL), a native Chinese herbal extract, has a wide range of pharmacological effects, such as anti-cancer, anti-inflammatory, antioxidant, and immune regulation. In this review, the anti-cancer effects and mechanisms of GL are summarized in various cancers. The inhibition of GL on chemotherapy-induced side effects, including hepatotoxicity, nephrotoxicity, genotoxicity, neurotoxicity and pulmonary toxicity, is highlighted. Therefore, GL may be a promising and ideal drug for cancer therapy. Frontiers Media S.A. 2023-08-15 /pmc/articles/PMC10463042/ /pubmed/37649893 http://dx.doi.org/10.3389/fphar.2023.1265172 Text en Copyright © 2023 Zhang, Sheng, Xiao, Li, Huang, Jia, Zeng and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, Yuqian Sheng, Zixuan Xiao, Jing Li, Yang Huang, Jie Jia, Jinjing Zeng, Xiansi Li, Li Advances in the roles of glycyrrhizic acid in cancer therapy |
title | Advances in the roles of glycyrrhizic acid in cancer therapy |
title_full | Advances in the roles of glycyrrhizic acid in cancer therapy |
title_fullStr | Advances in the roles of glycyrrhizic acid in cancer therapy |
title_full_unstemmed | Advances in the roles of glycyrrhizic acid in cancer therapy |
title_short | Advances in the roles of glycyrrhizic acid in cancer therapy |
title_sort | advances in the roles of glycyrrhizic acid in cancer therapy |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463042/ https://www.ncbi.nlm.nih.gov/pubmed/37649893 http://dx.doi.org/10.3389/fphar.2023.1265172 |
work_keys_str_mv | AT zhangyuqian advancesintherolesofglycyrrhizicacidincancertherapy AT shengzixuan advancesintherolesofglycyrrhizicacidincancertherapy AT xiaojing advancesintherolesofglycyrrhizicacidincancertherapy AT liyang advancesintherolesofglycyrrhizicacidincancertherapy AT huangjie advancesintherolesofglycyrrhizicacidincancertherapy AT jiajinjing advancesintherolesofglycyrrhizicacidincancertherapy AT zengxiansi advancesintherolesofglycyrrhizicacidincancertherapy AT lili advancesintherolesofglycyrrhizicacidincancertherapy |